Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAT: Clozapine + Aripiprazole vs Haloperidol in Schizophrenia
NCT00395915Phase 4Unknown
- Sponsor
- Università degli Studi di Verona
- Start
- Sep 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aripiprazole in schizophrenia (2 arms), sponsored by Università degli Studi di Verona. Primary endpoint: Withdrawal from allocated treatment at 3 months. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00395915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395915.